CAPTRUST FINANCIAL ADVISORS - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$11,000
+266.7%
563
+532.6%
0.00%
Q2 2021$3,000
+50.0%
89
+17.1%
0.00%
Q1 2021$2,000760.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$89,888,00013.40%
EcoR1 Capital, LLC 3,627,597$79,916,0007.20%
Aquilo Capital Management, LLC 614,436$13,536,0005.08%
RTW INVESTMENTS, LP 5,874,229$129,409,0004.88%
BRIDGER MANAGEMENT, LLC 1,981,633$43,655,0003.15%
ACUTA CAPITAL PARTNERS, LLC 387,500$8,537,0002.11%
Integral Health Asset Management, LLC 200,000$4,406,0001.72%
Burrage Capital Management LLC 104,047$2,292,0001.54%
Parkman Healthcare Partners LLC 240,000$5,287,0001.53%
EAM Global Investors LLC 122,237$2,693,0001.08%
View complete list of DICERNA PHARMACEUTICALS INC shareholders